Search - tctmd.com

Displaying 221 - 240 of 395

Sort: Relevancy | Date

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Daily News

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

Caitlin E. Cox

May 08, 2017

News Daily News

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Shelley Wood

April 12, 2017

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

Todd Neale

April 03, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

CT Angiography Moves to Forefront in Assessment of Chest Pain in UK

News Daily News

La Angiografía por TC a la Vanguardia en la Valoración del Dolor Torácico en el Reino Unido

Michael O'Riordan

December 07, 2016

News Daily News

CT 血管造影术在英国胸部疼痛评估中走向前列

Michael O'Riordan

December 07, 2016

News Daily News

CT Angiography Moves to Forefront in Assessment of Chest Pain in UK

Michael O'Riordan

December 07, 2016

News Daily News

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

L.A. McKeown

November 10, 2016

News Daily News

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Michael O'Riordan

October 24, 2016

News Daily News

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

Michael O'Riordan

October 18, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

Michael O'Riordan

July 27, 2016

News Daily News

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Michael O'Riordan

July 27, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Daily News

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

Leah Lawrence

May 25, 2016

News Daily News

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Leah Lawrence

May 25, 2016

Advertisement

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Masters Athletes at Low Risk for CAD Seem to Develop Atherosclerosis Differently, Study Suggests

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

La Angiografía por TC a la Vanguardia en la Valoración del Dolor Torácico en el Reino Unido

CT 血管造影术在英国胸部疼痛评估中走向前列

CT Angiography Moves to Forefront in Assessment of Chest Pain in UK

Periprocedural MI Predicts Mortality After PCI for Chronic Total Occlusion

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

PLATFORM: Ante Sospecha de EAC la Estrategia de Guiado mediante FFRTC ‘Tiene una Duración’ de 1 Año

PLATFORM：FFRCT 指导的策略在疑似 CAD 患者中可“坚持”到 1 年

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

CTA Both Clinically, Economically Comparable to Functional Testing for Suspected CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content